Co-founder and Chief Scientific Officer of Zero Dementia. Arshi leads the scientific methods and studies behind the cognitive assessment, from task design and scoring rules to the validation roadmap.
Arshi Niyaz
Scientific methods & studies
Vision
A cognitive assessment is only useful if its results mean the same thing for every person. Arshi's focus is the science behind Zero Dementia: tasks that adapt fairly to schooling and language, scoring rules that a clinician can follow step by step, and a clear line between what the assessment measures and what it does not.
The validation roadmap runs from a feasibility pilot to a reference-assessment study, peer-reviewed publication and the CDSCO pathway. New signals such as voice and eye movement are studied with the same care before they are used in any decision.
Screen earlier. Healthier tomorrow.
What Arshi leads
The scientific work Arshi leads.
Scientific principles
Measure the person, not their schooling
Each task has forms for different education levels and languages.
Say what it does not do
No diagnosis and no norms yet. The evidence page lists what is and is not measured.
Missing is never wrong
Declined, unable or not given is recorded as such, never as zero.
Safety before testing
Stroke, delirium and crisis are checked before the first task.
Publish and review
Methods and results go through peer review before claims are made.
Method
Writing
Arshi Niyaz is the co-founder and Chief Scientific Officer (CSO) of Zero Dementia, a product of Biotech Wallah Private Limited in Lucknow, India.
She leads the scientific methods and studies behind the cognitive assessment: task design, scoring rules and the validation roadmap.
Through a feasibility pilot, a reference-assessment study, peer-reviewed publication and the CDSCO regulatory pathway, with ethics approval first.
By email at arshi@biotechwallah.com, or on LinkedIn. For research collaboration, use the research form on zerodementia.com.
For validation studies, MCI cohorts or clinical research, talk to Arshi.
